Could virtual reality ease the mental toll of ICU stays?

NCT ID NCT06267911

Ongoing Symptom relief Sponsor: University of the Balearic Islands Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a non-immersive virtual reality program (RGS-ICU) for ICU patients. The program includes daily 20-minute sessions of cognitive exercises and psychological support alongside standard care. Researchers will enroll 93 adults in ICUs for respiratory failure, cardiogenic shock, or septic shock. The goal is to see if this approach improves comfort during the ICU stay and boosts thinking and mental health up to 12 months after discharge.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: non-immersive virtual reality-based cognitive stimulation and psychological support program (RGS-ICU)
What this could lead to: If it works, this could offer a safe, drug-free way to help ICU survivors recover thinking skills and emotional well-being, reducing long-term mental health issues.
What could go wrong: This is a small, early-stage trial with only 93 participants. The program may not show clear benefits over standard care, and some patients may not tolerate the sessions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICAL ILLNESS

Contacts and locations

Locations

Corporacion Parc Tauli

Sabadell, Catalonia, 08208, Spain
Hospital Universitari Son Llàtzer

Palma de Mallorca, Balearic Islands, 07198, Spain
University of the Balearic Islands

Palma de Mallorca, Balearic Islands, 07122, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.